These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Modulation of B16 melanoma antigen expression by lymphokines and dimethyl sulfoxide. Trimpe KL, Zwilling BS. Cancer Res; 1986 Oct; 46(10):4953-9. PubMed ID: 3756856 [Abstract] [Full Text] [Related]
31. In situ analysis of antigens on malignant and benign cells of the melanocyte lineage. Differential expression of two surface molecules, gp75 and p89. Holzmann B, Johnson JP, Kaudewitz P, Riethmüller G. J Exp Med; 1985 Feb 01; 161(2):366-77. PubMed ID: 3973533 [Abstract] [Full Text] [Related]
32. A cell surface 230 kDa protein from murine melanoma involved with tumor malignancy. Mendes PF, Xander P, Novaes e Brito RR, Mortara RA, Jasiulionis MG, Lopes JD. Cancer Lett; 2008 Apr 18; 262(2):276-85. PubMed ID: 18226856 [Abstract] [Full Text] [Related]
34. Surface antigenic profile of uveal melanoma lesions analysed with a panel of monoclonal antibodies directed against cutaneous melanoma. Carrel S, Schreyer M, Gross N, Zografos L. Anticancer Res; 1990 Apr 18; 10(1):81-9. PubMed ID: 1692197 [Abstract] [Full Text] [Related]
38. Monoclonal antibodies to 125 kd and 95 kd proteins on human melanoma cells: comparison with other monoclonal-defined melanoma antigens. Saxton RE, Mann BD, Morton DL, Burk MW. Hybridoma; 1982 Dec 18; 1(4):433-45. PubMed ID: 6208138 [Abstract] [Full Text] [Related]
39. Serological and biochemical analyses of monoclonal antibodies to human melanoma-associated antigens. Harper JR, Bumol TF, Reisfeld RA. Hybridoma; 1982 Dec 18; 1(4):423-32. PubMed ID: 6208137 [Abstract] [Full Text] [Related]